Streetbeat News

Stock Prices

RPHM

Reneo Pharmaceuticals (NASDAQ:RPHM) reported a significant improvement in its Q2 2024 GAAP EPS, with losses narrowing to $(0.16) per share from $(0.65) per share in the same period last year, marking a 75.38% increase.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:50 am

IYE

XLE

XOM

Exxon Mobil Corporation (NYSE:XOM) is trading lower premarket after issuing layoff notices to 59 employees following its $60 billion acquisition of Pioneer Natural Resources. Despite offering jobs to over 1,500 of Pioneer's employees, the restructuring has led to workforce reductions. Exxon recently reported strong Q2 results, beating revenue and EPS estimates.

Portfolio Pulse from Lekha Gupta

August 13, 2024 | 11:50 am

SYPR

Sypris Solutions has reiterated its full-year 2024 outlook, expecting a 10-15% year-over-year revenue growth. The company also anticipates a 20-25% increase in gross profit and an expansion of gross margins by 100-125 basis points.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:49 am

CING

Cingulate reported a Q2 2024 GAAP EPS of $(5.47), which is significantly lower than the estimated $(0.47).

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:47 am

VGAS

Verde Clean Fuels (NASDAQ:VGAS) reported a Q2 EPS of $(0.14), a 16.67% decrease from $(0.12) YoY. The company ended the quarter with $23.2 million in cash and cash equivalents.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:43 am

HD

NVDA

PSFE

QQQ

SE

SPY

TME

VSAT

Wall Street is optimistic about benign inflation data, which could lead to a rate cut. Home Depot's weak guidance is weighing on the retail sector. Futures for Nasdaq and S&P 500 are slightly up, while Dow and Russell 2000 are down. Key stocks like Home Depot, Tencent Music, Sea Limited, Paysafe, and Viasat are experiencing significant premarket movements.

Portfolio Pulse from Shanthi Rexaline

August 13, 2024 | 11:41 am

CYBN

Cybin has completed an FDA Type B initial breakthrough therapy meeting and plans to initiate a Phase 3 program for CYB003 in treating major depressive disorder by late summer.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:40 am

HD

Home Depot (NYSE:HD) reported Q2 2024 earnings with a slight revenue miss and a decline in customer transactions. Despite weaker home improvement spending, the company raised its annual revenue outlook. HD shares are trading lower by 2.36% in the premarket.

Portfolio Pulse from Akanksha Bakshi

August 13, 2024 | 11:39 am

LUNR

Intuitive Machines has updated its 2024 revenue outlook to $210M-$240M, slightly higher than the previous lower bound of $200M. The company expects a 2.6x-3x increase in sales compared to the prior year. The Q2 cash balance is expected to be sufficient to fund operations for the next 12 months. The company is also expanding its backlog with key upcoming awards and plans to ship its mission two completed lander by Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:38 am

CYBN

Cybin is set to commence its Phase 3 pivotal program for CYB003 in late summer, following a Type B Initial Breakthrough Therapy meeting with the FDA. The company has selected 30 clinical sites across the US and Europe. In Phase 2, CYB003 showed a 75% remission rate from depression four months after two 16mg doses. Cybin expects to report 12-month efficacy data from Phase 2 in Q4 this year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:37 am